home

Sandoz receives EC approval for subcutaneous route of administration in biosimilar Binocrit's® nephrology indication

GenericNovartis2016-04-11 11:11 Read   189

Sandoz, a Novartis division and the global leader in biosimilars, announced today that the European Commission (EC) has approved a type II variation for the addition of a subcutaneous (s.c.) route of administration in Binocrit's® (epoetin alfa) nephrology indication*.

FDA approves Inflectra, a biosimilar to Remicade

GenericFDA2016-04-06 09:14 Read   135

The U.S. Food and Drug Administration today approved Inflectra (infliximab-dyyb) for multiple indications. Inflectra is administered by intravenous infusion. This is the second biosimilar approved by the FDA.

Teva Wins FDA Approval for First Viagra Generic, Will Not Launch Until 2017

GenericTeva2016-03-14 14:51 Read   179

Teva Pharmaceuticals will take a bite out of Pfizer’s blockbuster Viagra (sildenafil citrate) sales as the US Food and Drug Administration approved a generic version of the erectile dysfunction drug on Wednesday.